Immunotherapy in metastatic renal cell carcinoma: Insights from a Dutch nationwide cohort

Immunotherapy in metastatic renal cell carcinoma: Insights from a Dutch nationwide cohort

Targeted therapy with tyrosine kinase inhibitors (TKIs) was the standard of care for metastatic renal cell carcinoma (mRCC) until recently, when new first-line combinations with immuno-oncology (IO) agents were approved. We evaluated IO uptake in both first-line and later-line treatment in routine c...

Full description

Saved in:
Bibliographic Details
Main Authors: Hilin Yildirim, Anke Richters, Adriaan D. Bins, Arnoud W. Postema, Maureen J.B. Aarts, Martijn G.H. van Oijen, Patricia J. Zondervan, Katja K.H. Aben
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:European Urology Open Science
Subjects:
Metastatic renal cancer
Metastatic renal cell carcinoma
Immune checkpoint inhibitors
Immunotherapy
Overall survival
Survival
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168325000503
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2666168325000503

Similar Items